Radionuclide Therapy (SPE151)

Work-based learning outcomes

  1. Advise on the choice of radiopharmaceutical for radionuclide therapy in terms of the physical properties of the radionuclide, the physiological properties of the radiopharmaceutical and the clinical context of the procedure
  2. Advise on and perform practical aspects of the administration of radionuclide therapy to patients
  3. Specify, and explain to the patient, the post-therapy behavioural restrictions placed on them
  4. Specify the facilities required for radionuclide therapy
  5. Implement and advise on the principles of management of radiation safety associated with radionuclide therapy administrations and patients
  6. Undertake practical radiation safety tasks required to deliver a service, including the effective communication of risk, decontamination procedures and radioactive waste management
  7. Specify and perform the radiation monitoring of inpatients to determine their point of release
  8. Implement the principles of internal radiation dosimetry, patient-specific dosimetry protocols and their requirements for data acquisition and analysis
Number Work-based learning outcome Title Knowledge
1 2,3,4,7

Generate or critically review the design of suitable equipment and facilities for patient therapies-

2 1,2

Advise on the appropriateness of requests for the administration of radionuclide therapy

3 1,2,3

Prepare or critically review a radiation risk assessment for the administration of a particular form of radionuclide therapy

4 2,3,5

Write or critically review standard operating procedures for the administration of particular form(s) of radionuclide therapy, incorporating the results of the risk assessment

5 2,3

Perform a tailored radiation risk assessment and instructions for those in contact with an individual radionuclide  therapy outpatient

6 2,3,4,5,7

Prepare or review written instructions for staff on the management of inpatients receiving a particular radionuclide therapy, and give advice to staff in accordance

7 2,6

Actively contribute to the administration of a range of radionuclide therapies, including at least iodine-131 for thyroid cancer and benign thyroid disease

8 2,6

Assist and advise medical practitioners in the administration of non-oral radionuclide therapies, eg by intravenous infusion

9 3

Advise patients and their carers on appropriate post-therapy behavioural restrictions

10 7

Actively participate in the monitoring of inpatients to determine effective half-life and/or residual activity and managing the criteria for release of inpatients based on the results of this monitoring

11 6

Perform contamination monitoring and decontamination of a treatment room post radionuclide therapy administration

12 6

Record, store and dispose of radioactive waste produced as a result of radionuclide therapy

13 1-8

Participate in clinical audit of radionuclide therapy

14 7,8

Actively participate in acquisition of imaging data and/or data from radiation detectors/monitors

15 8

Actively participate in calculating absorbed radiation doses to target and non-target tissues for therapy protocols guided by patient-specific dosimetry

You must complete
1 Case-based discussion(s)
1 of the following DOPS / OCEs
Assessment Title Type
Monitor a patient in the therapy room DOPS
Administer a therapy for benign thyroid disease, under supervision DOPS
Set up under supervision a therapy infusion DOPS
Decontaminate a therapy room once the patient has left DOPS
Analyse the monitoring data to calculate the activity remaining in a therapy patient when they leave hospital. DOPS
Prepare instructions for a therapy patient on leaving hospital. DOPS
Calculate the total activity administered to a patient by calculating activity of waste. Record results and store waste appropriately. DOPS
Perform a tailored risk assessment for a patient undergoing out-patient therapy. DOPS
Explain details of a therapy administration to a patient OCE
Explain precautions to a patient who has had Radioiodine therapy for benign thyroid disease OCE
Explain precautions to a patient who has had Radioiodine therapy for thyroid cancer. OCE
Explain monitoring procedure to a therapy patient OCE
Give a presentation about the shielding requirements of different types of radionuclide therapy. OCE